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INTRODUCTION:
Due to the changing bacteriology and m ulti-drug resistant nature o f osteomyelitis (bone infections) associated with war wounds, choos ing appropriate antim icrobial therapy is a challenging task Johnaon, 2007; Murray, 2006; Yun, 2008) . One alternative approach to antibiotics includes the use of near infr ared (IR) radiation to therm ally kill pathogenic organ isms (Kam, 2005; Zharov, 2006) . W hereas near IR wav elengths pass harmlessly through the human body, they are known to heat gold nanoshells to high temperatures (>70°C), which in principle will therm ally ablate any cell (bacterial or eukaryotic) in close proximity to these pa rticles. Due to the ra pid dissipation of therm al energy over very short distances, it is speculated that on ly cells in d irect contact with gold particles will be killed and surrounding tissues will be unaffected (Hu, 2006) . The challenge to this approach is to develop a system to bind the gold nanoparticles to the surface of targeted cells. Our aim is to use a scaffold protein, PlyCB, which can be functionalized to bind gold nanopa rticles as well as bacterialspecific targeting dom ains. PlyCB is stable up to 100°C, resistant to proteolysis, high ionic strength, extreme pH conditions, and most detergents, m aking it a perfect platform for engineering. The "top" surface of PlyCB will be m odified to contain cysteine residues to covalently bind gold nanoparticles (Fig 1) . The "bottom" surface of PlyCB inherently binds streptococcal cells with nano molar affinity, which will be used for proof-ofprinciple thermal ablation studies. W e further propose to engineer the "bottom" surface to contain an array of binding domains isolated f rom tail f ibers of bacteriophage that are specific for osteomyelitis causing pathogens.
BODY:
Aim 1. Make PlyCB/Gold nanocomplexes.
Task 1. Obtain reagents. (month 1)
All reagents have been obtained. The gold nanoparticles causes us the most trouble. Initially, we were using 100 nm gold nanoparticles (round balls ). However, after fi ne tuning our infrared spectrophotometer and receiving more technical advice from the vendor, we found that a nanorod, not a sphere, produced better surface plas mon resonance for our applications. We now have normal nanorods as well as neutravidin-coated rods. Fig. 1 . Left, PlyCB with a Ser to Cys m utation at th e Nterminal amino acid. Righ t, gold particles will bind PlyCB via the cysteine residues, making the PlyCB/gold nanoparticle complex that can be used for thermal ablation studies.
Task 2. Make PlyCB mutations (change serine at position 1 to cysteine (S1C mutant). (month 1-3)
The single point m utant (Ser at position 1 to cystein e) was eas ily accomplished by a QuickChange Mutagenesis kit. The S1C m utant was expressed, purified, and confirm ed to contain the mutation by both m ass spectral analysis and N-terminal sequence analysis (data not shown). Additionally, we confirmed by analytical gel filtration that the mutant had no adverse affect on formation of the PlyCB octamer. We were able to generate ~50 mg of pure S1C m utant from a 6L fermentation.
Task 3. Make PlyCB/gold nanoparticle complex. (month 4-9)
Initially, 1 mg of the S1C m utant of PlyC was reacted with ~1x10 10 gold nanoparticles (nps)/m l and purified by size exclusion chromatography (Fig. 2) . The chemistry involved relied on free, reduced sulfhydral m oieties of the cysteine residues to interact directly with the gold. This approach was very successful at forming the com plex. However, the complexes were "sticky" and would often bind to the container they were stored in or they would aggregate a nd fall out of solution. To solve this problem, we switched to using gold nanoparticles th at were coated with a neutravi din shell. In order to bind to the neutravidin, we biotinylated the cysteine residues of the S1C mutant. Although this was a setback, we did achieve formation of the complex, were able to purify it, and successfully store it without aggregation issues (data not shown).
Another issue we encountered (later in Aim 2), caused us to return to this task. Namely, the 100 nm spherical gold nanoparticles we were using were not optimized for thermal ablation by near infrared spectroscopy. Through trial and error, we determined a gold nanorod, roughly 10 nm x 30 nm, gave the best surface plas mon resonance for therm al ablation studies b y infrared radiation. Thankfully, the vendor made neutravidin rods in the size/length we required. We now have a stock of PlyCB/gold nanorod complexes for future studies.
Next, we chemically crosslinked the complex with a fluorophore (AlexaFluor 488), mixed it with streptococcal cells, washed, and viewed under bright field and fluorescent microscopy. As can be seen in Fig. 3 , gold nanoparticles adhered to th e surface of the streptococci. W e wanted to determine if this binding event was specific for the streptococcal surface or simply an artifact of a "sticky" complex. Therefore, we repeated the experim ent in the presence of bot h streptococci and E. coli, a non-target host for PlyCB. As can be seen in Fig. 4 , the PlyCB/gold nanoparticle complex specifically binds streptococci. Aim 2. Proof-of-principle thermal ablation experiments.
Task 1. Irradiation and power tests. (month 9-10)
Before we can perform irradiation and power test on our nanocomplexes, we needed to do some basic studies on how much heat is needed to kill streptococci and at what duration. Therefore, we heated streptococci to various temperatures for different am ounts of time. As shown in Fig.  5 , all streptococci (i.e. 10 7 ) were killed when exposed to 50°C for 10 minutes. However, when PlyCB was labeled with a fluorophore before being complexed to the gold nanoparticles. As such, the particles can be seen as bright red spheres. Fig. 4 . The same experiment as in Figure 3 , but this time, E. colie was m ixed with streptococci. The PlyCB/gold complexes specifically bind streptococci (white arrows) bu t not the E. coli. the temperature was raised to 60°C, only 10 se conds was needed to produce a 4 log drop in viability and 65°C ster ilized the culture. Giv en that thermal ablation can produ ce very high temperatures, we may only need a fraction of a second of contact time.
Finally, we were ready for power testing. As can be seen in Fig. 6 , just 5 or 10 milijules of laser power was sufficient to produce a strong resonant energy. We are may be sufficient for thermal ablation studies.
Task 2. Bacterial ablation testing. (month 11-13)
In our initia l bacterial ablation experiments, it a ppeared as if therm al ablation of streptococci worked at all power settings (data not shown). However, we noticed that controls where infrared lasing did not occur also produced a significant drop in viability. Therefore, we had imm ediate concerns that the gold nanoparticles themselves were toxic to streptococci. Ind eed, as seen in Fig. 7 , bare gold nanoparticles were som ewhat toxic to the bacteria in the absence of near infrared lasing. However, the neutravidin-coated particles were found to be non-toxic . Current/future experiments will o nly use th e neutravidin-coated particles bound to the biotinylated S1C m utant of Pl yCB. Significantly, our most re cent data does show thermal ablation of streptococcal strain D471 by ne utravidin gold nanoparticles both alone and complexted with PlyCB (Fig. 8) .
Aim 3. Engineer bacteriophage tail fiber domains.
Task 1. Obtain and characterized bacteriophage. (month 1-6)
We have obtained several phage through depositorie s or international collaborators. Sequencing has been an issue and even when sequencing is available, there is a bit of a bio informatic bottleneck trying to elu cidate which domains on a tail fiber are responsible for binding to the bacterial surface and which dom ains are structural. Nonetheless, we hav e identified a binding domain on a pneumococcal phage that we believe is responsible for binding to the surface. This will serve us for our proof of concept studies.
Task 2. Make PlyCB/gold nanoparticle constructs with selected phage tail fiber or lysin binding domains. (month 7-12)
As stated above, we have iden tified a pneumoc occal binding domain for proof of princip le experiments, synthesized this gene, and m ade a fusion of this gene to th e C-terminal domain of PlyCB (data not shown). W e are currently in the pro cess of expressing th is chimera and evaluating its solubility. Fig. 7 . "B are" gold nanoparticles was t oxic to streptococcal strain D471, but when the same particles were coated with neutravidin, toxicity was avoided. Fig. 8 . 6x10 6 colony forming units/ml of streptococcal strain D471 was mixed with 6x10 10 nanoparticles/ml and i rradiated with 50 pulses of a 5 mJ laser at 569 nm. Only wells containing gold nanoparticles were sterilized.
KEY RESEARCH ACCOMPLISHMENTS:
 Successfully created S1C mutation of PlyCB  Made PlyCB/gold nanoparticle complexes  Demonstrated that PlyCB/gold nanoparticle complexes retain specific binding to streptococcal cells  Overcame hurdles with respect to size/shape of gold nanoparticle and toxicity of uncoated gold nanoparticles  Demonstrated resonance energy output from nanoparticles lased with near infrared radiation  Demonstrated thermal ablation of streptococci with PlyCB/gold nanoparticle complexes  Created a chimeric fusion of PlyCB with a pneumococcal binding domain
REPORTABLE OUTCOMES:
Some aspects of our prelim inary data and/or overall strategy have been presented at the following meetings/symposia during the past year: 
CONCLUSION:
Our results have been consistent with our expect ations. We had several technical hurdles with the size of the gold nanoparticle and toxicity of bare nanoparticles, but we have overcom e these issues. More im portantly, we successfully made the required S1C mutation, form ation of PlyCB/gold nanoparticle com plexes was straight -forward, and as expected, the com plexes retained the species-specific binding properties of wild-type PlyCB. The final six m onths of the project will be spent further dem onstrating the thermal ablation properties of the complexes and evaluating if we can change specificity of the complex by addition of a non-host binding dom ain to the C-terminus of PlyCB (i.e. the pneumococcal binding domain).
If successful, this generalized bioengineering scheme can be applied to a wide range of pathogens.
Antibodies with covalently att ached gold nanoparticles (GNPs) have been demonstrated to thermally destroy tum or cells when exposed to wavelengths that m atch the surface plasm on resonance frequency of the GNP. The intense heat generated is highly localized and sufficient to kill the target cell without harming adjacent, healthy cells. Using this principle, we proposed to attach GNPs to the bacteriophage C 1 endolysin binding dom ain protein, PlyCB, which spontaneously forms an octam eric ring that disp lays distinct sidedness. The N-term inal "top" contains a flexible N-term inus that does not participate in ring form ation, and a C-term inal "bottom" with nanom olar affinity for the cell su rface of streptococcal sp ecies. This octamer is highly resistant to proteolysis, high ionic strength, extrem e pH conditions, and is stable up to 100°C, making PlyCB an excellent platform for antimicrobial thermal ablation nanotechnology studies. Toward this end, PlyCB was engineered to contain an N-terminal Cys residue on each monomer. The recom binant enzyme was then expr essed, purified, and c ovalently attached to 100 nm GNPs through the Cys r esidues. PlyCB/GNP complexes were then purified by gel filtration. AlexaFluor was chem ically crosslinked to Ply CB/GNP complexes, which were shown to retain specific ity to th e streptococcal surface by ep ifluorescent microscopy. Next, a Type-J thermocouple and a tunable laser were used to m easure the heating properties of PlyCB/GNP complexes in solution. Finally, PlyCB/GNP complexes bound to streptococci were irradiated at 569 nm which was shown to reduce viable streptococcal bacteria in culture by more than 4 logs. Thus, the destruction of stre ptococci with P lyCB/GNP complexes by therm al ablation demonstrates the utility of this approach for antimicrobial applications.
